Target intelligence / Profile preview

Ataxia telangiectasia and Rad3 related (ATR)

Target
ATR
Molecular classification
Protein Kinase, Serine/Threonine Kinase, PI3K-related kinase (PIKK)
01

Overview

Ataxia telangiectasia and Rad3 related (ATR) is a serine/threonine protein kinase that plays a central role in the DNA damage response (DDR), particularly during DNA replication and in response to DNA damage. It is a key sensor of single-stranded DNA associated with stalled replication forks or intermediates generated during base excision repair (BER) and double-strand break repair. Upon activation, ATR initiates checkpoint signaling cascades that halt cell cycle progression for damage assessment/repair and phosphorylates downstream effectors like Chk1. Inhibitors targeting ATR are being developed as potential cancer therapeutics, especially for tumors with defects in other DDR components.

Other names
Serine/threonine-protein kinase ATRFRAP-related protein 1FRP1
02

Mechanism of action

ATR inhibitors block the kinase activity of ATR, preventing the activation of downstream checkpoint signaling and DNA repair pathways, ultimately leading to cell death, especially in cells with other DDR defects.

03

Biological functions

DNA Damage Response (DDR)Cell cycle checkpoint controlDNA replicationDNA repairGenome stabilityApoptosis regulationSignal transduction
04

Disease associations

CancerAtaxia-Telangiectasia
05

Safety considerations

MyelosuppressionOff-target effects on other kinasesDevelopment of resistancePotential for increased sensitivity to chemotherapy/radiation in normal tissues
06

Interacting drugs

ATR inhibitors (e.g., VX-970, Berzosertib)

1 more in the full profile.

07

Biomarkers

Expression levels of ATR and other DDR proteinsPresence of mutations in other DDR genes (e.g., ATM, BRCA1/2)Extent of DNA damage (e.g., γH2AX levels)

Beyond the preview

Go deeper on Ataxia telangiectasia and Rad3 related (ATR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ataxia telangiectasia and Rad3 related (ATR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call